Bringing doctors together

or

A free, private network for verified physicians

Leading voices

Dr. Aisha Shaikh

General Nephrology · UPenn

View

Dr. Anna Gaddy

General Nephrology · MCW

View

Dr. Laura Maursetter

General Nephrology · UW

View

Dr. Lavinia Negrea

General Nephrology · CWRU

View

Dr. Chi-yuan Hsu

General Nephrology · UCSF

View

Dr. Adam Weinstein

General Nephrology · DaVita

View

Dr. Daniel Batlle

General Nephrology · Northwestern Medicine

View

Dr. Sushrut Waikar

General Nephrology · BMC

View

Dr. Keith Bellovich

General Nephrology · HFHS

View

Dr. Steven Fishbane

General Nephrology · Northwell Health

View
  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms

    Overview

    Finerenone in Type 1 Diabetes and Chronic Kidney Disease

    Mar 5, 2026DOI: 10.1056/nejmoa2512854Original ArticleNEJM

    Written by: Hiddo J.L. Heerspink, Ph.D.Andreas L. Birkenfeld, M.D.David Z.I. Cherney, M.D., Ph.D.Helen M. Colhoun, M.D.Per-Henrik Groop, M.D.Linong Ji, M.D.Niels Jongs, Ph.D.Chantal Mathieu, M.D.Richard E. Pratley, M.D.Sylvia E. Rosas, M.D., M.S.C.E.Peter Rossing, M.D.Jay S. Skyler, M.D.Katherine R. Tuttle, M.D.Robert Lawatscheck, M.D.Meike Brinker, M.D.Markus F. Scheerer, Ph.D.Julie Russell, M.Sc.Patrick Schloemer, Ph.D.Janet B. McGill, M.D.

    Find these authors on Roon

    KT
    Dr. Katherine Tuttle
    General Nephrology · Providence Health

    Summary

    In adults with type 1 diabetes and chronic kidney disease with albuminuria, the decrease in the urinary albumin-to-creatinine ratio was significantly greater with finerenone than with placebo.
    KTDr. Katherine Tuttle

    Dr. Katherine Tuttle

    Nephrology · General Nephrology
    Providence Health
    katherinet